Eli Lilly's CFO explains why the company's newest weight-loss drug Zepbound will cost 20% less than the current options - Yahoo Finance

Genaro Donaro Urology Reply noviembre 29, 2023

Publicar un comentario

Buscar

twitter

Pinterest

Facebook Page

Twitter

Instagram

Facebook

Quora

Youtube

Reddit

Noticias